StockData
Immatics N.V. logo

Immatics N.V. (IMTX) stock

IMTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 5, 2026Score 1/30
$6.29+0.12 (+1.94%)

Close on Nov 17, 2026Market cap $843.31MP/E –Yield –

Immatics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Immatics's pe ratio was 62.5× on Feb 27, 2026, against 28.9× a year earlier. Over the last 2 years it ranged from 15.9× to 65.8×, with a median of 29.8×.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Feb 27, 202662.5×−1.4
2025Dec 31, 202563.9×+35.0
2024Feb 29, 202428.9×+5.1
2023Dec 29, 202323.8×–

More Immatics figures

See a number that looks wrong?